Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Total Debt (2020 - 2025)

Treace Medical Concepts' Total Debt history spans 6 years, with the latest figure at $57.3 million for Q4 2025.

  • For Q4 2025, Total Debt rose 7.55% year-over-year to $57.3 million; the TTM value through Dec 2025 reached $57.3 million, up 7.55%, while the annual FY2025 figure was $57.3 million, 7.55% up from the prior year.
  • Total Debt reached $57.3 million in Q4 2025 per TMCI's latest filing, up from $55.3 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $57.3 million in Q4 2025 to a low of $29.2 million in Q1 2021.
  • Average Total Debt over 5 years is $47.5 million, with a median of $52.9 million recorded in 2023.
  • Peak YoY movement for Total Debt: fell 5.2% in 2021, then soared 79.53% in 2022.
  • A 5-year view of Total Debt shows it stood at $29.4 million in 2021, then surged by 79.5% to $52.7 million in 2022, then increased by 0.56% to $53.0 million in 2023, then increased by 0.56% to $53.3 million in 2024, then rose by 7.55% to $57.3 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Total Debt are $57.3 million (Q4 2025), $55.3 million (Q3 2025), and $54.6 million (Q2 2025).